Do you provide Structural protein synthesis?
Measuring fibronectin, laminin and other structural proteins
Fibronectin links cells to collagen fibres and guides how new matrix is laid down. Laminins form part of the basement membrane that anchors the epidermis to the dermis, together with collagen IV and collagen VII. Testing quantifies how an active changes the amount and location of these proteins, complementing dedicated collagen synthesis and elastin production studies.
Matching the model to the protein
Fibronectin is made mainly by dermal fibroblasts, so fibroblast monolayers suit it well. Basement membrane proteins come from both keratinocytes and fibroblasts, and a full-thickness skin model or human skin explant shows where they are deposited. The laboratory selects the model once you name the target protein.
From gene to deposited matrix
Each level of measurement answers a different question:
- qPCR for target gene expression
- ELISA for secreted protein in the culture medium
- Western blot for cell-associated protein
- Immunofluorescence for deposition and localisation
- Viability and cell-number normalisation
Concentration-response and time-course designs show how the response builds, and untreated, vehicle and reference controls run alongside every condition.
Per-protein results and stained tissue sections
The report states the model, exposure, antibodies and analytical methods, then gives results per protein and per level of measurement, with statistics against controls. Tissue studies include stained sections and image quantification, for example fluorescence intensity along the dermal-epidermal junction. Images are supplied at publication resolution for use in technical literature.
Where structural protein data fit in an ingredient dossier
Structural protein results add matrix evidence beyond collagen to an active’s file, which technical buyers notice when they compare ingredients.
Building a protein-specific claim
Claims in this area are strongest when they name the protein and the model, for example increased laminin deposition at the junction in a reconstructed skin model. That level of precision is what formulators and technical buyers look for when they compare actives. Decide which protein matters to your claim before asking for a quote, since each target needs its own antibodies and validation.
Combining with other matrix studies
Structural proteins are one part of the dermal matrix. Ingredients positioned on overall matrix density often pair this study with proteoglycan synthesis testing and a hyaluronic acid measurement, so that proteins, glycosaminoglycans and proteoglycans are all covered. Running them on the same model and donor cells keeps the results comparable.
Choosing a laboratory for junction work
For dermal-epidermal junction claims, look for a provider that runs full-thickness skin models or explants routinely and has validated immunostaining for laminin 332, collagen IV and collagen VII. Ask to see example images and the image analysis method they use to quantify staining, since this determines how convincing the final figures look in your dossier.
More in ECM & Skin Ageing
ECM & Skin Ageing testing measures how actives affect collagen, elastin, matrix enzymes, glycation and senescence in skin cell and tissue models.













